The inhibition of SCN function could improve the inflammatory response after myocardial infarction and promote cardiac repair by upregulating BMAL1 to promote insulin-like growth factor 2 (Igf2) expression and inducing macrophage conversion to an anti-inflammatory phenotype [78]. The gene discussed is IGF2; the disease is myocardial infarction.